1,492
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Predictors of decline in kidney function in the general population: a decade of follow-up from the Tehran Lipid and Glucose Study

, , , ORCID Icon &
Article: 2216020 | Received 16 Jan 2023, Accepted 15 May 2023, Published online: 05 Jun 2023

References

  • Bikbov B, Purcell CA, Levey AS, et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395(10225):1–14.
  • Tabatabaei-Malazy O, Saeedi SM, Khashayar P, et al. Regional burden of chronic kidney disease in North Africa and Middle East during 1990–2019; results from global burden of disease study 2019. Front Public Health. 2022;10:1015902.
  • Hosseinpanah F, Kasraei F, Nassiri AA, et al. High prevalence of chronic kidney disease in Iran: a large population-based study. BMC Public Health. 2009;9(1):1–8.
  • Tohidi M, Hasheminia M, Mohebi R, et al. Incidence of chronic kidney disease and its risk factors, results of over 10 year follow up in an Iranian cohort. PLOS One. 2012;7(9):e45304.
  • Barzilay JI, Davis BR, Pressel SL, et al. The effects of eGFR change on CVD, renal, and mortality outcomes in a hypertensive cohort treated with 3 different antihypertensive medications. Am J Hypertens. 2018;31(5):609–614.
  • Thompson S, James M, Wiebe N, et al. Cause of death in patients with reduced kidney function. J Am Soc Nephrol. 2015;26(10):2504–2511.
  • Coresh J, Turin TC, Matsushita K, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA. 2014;311(24):2518–2531.
  • Shlipak MG, Katz R, Kestenbaum B, et al. Rapid decline of kidney function increases cardiovascular risk in the elderly. J Am Soc Nephrol. 2009;20(12):2625–2630.
  • Guo Y, Cui L, Ye P, et al. Change of kidney function is associated with all‐cause mortality and cardiovascular diseases: results from the Kailuan study. J Am Heart Assoc. 2018;7(21):e010596.
  • Turin TC, James MT, Jun M, et al. Short‐term change in eGFR and risk of cardiovascular events. J Am Heart Assoc. 2014;3(5):e000997.
  • Carrero JJ, Hecking M, Chesnaye NC, et al. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol. 2018;14(3):151–164.
  • Eriksen BO, Ingebretsen OC. The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int. 2006;69(2):375–382.
  • Neugarten J, Acharya A, Silbiger SR. Effect of gender on the progression of nondiabetic renal disease: a meta-analysis. J Am Soc Nephrol. 2000;11(2):319–329.
  • Halbesma N, Brantsma AH, Bakker SJL, et al. Gender differences in predictors of the decline of renal function in the general population. Kidney Int. 2008;74(4):505–512.
  • Kronborg J, Solbu M, Njølstad I, et al. Predictors of change in estimated GFR: a population-based 7-year follow-up from the Tromsø study. Nephrol Dial Transplant. 2008;23(9):2818–2826.
  • Minutolo R, Gabbai FB, Chiodini P, et al. Sex differences in the progression of CKD among older patients: pooled analysis of 4 cohort studies. Am J Kidney Dis. 2020;75(1):30–38.
  • Jafar TH, Schmid CH, Stark PC, et al. The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis. Nephrol Dial Transplant. 2003;18(10):2047–2053.
  • Qin X, Wang Y, Li Y, et al. Risk factors for renal function decline in adults with normal kidney function: a 7-year cohort study. J Epidemiol Community Health. 2015;69(8):782–788.
  • Young BA, Katz R, Boulware LE, et al. Risk factors for rapid kidney function decline among African Americans: the Jackson Heart Study (JHS). Am J Kidney Dis. 2016;68(2):229–239.
  • Wang F, Zhang L, Zuo L, et al. Mortality and renal function decline among a community-based Chinese population with normal or mildly impaired renal function. Nephrol Dial Transplant. 2011;26(9):2847–2852.
  • Yokoyama H, Kanno S, Takahashi S, et al. Determinants of decline in glomerular filtration rate in nonproteinuric subjects with or without diabetes and hypertension. Clin J Am Soc Nephrol. 2009;4(9):1432–1440.
  • Jiang S, Sun X, Gu H, et al. Age-related change in kidney function, its influencing factors, and association with asymptomatic carotid atherosclerosis in healthy individuals—a 5-year follow-up study. Maturitas. 2012;73(3):230–238.
  • Halbesma N, Jansen DF, Stolk RP, et al. Changes in renal risk factors versus renal function outcome during follow-up in a population-based cohort study. Nephrol Dial Transplant. 2010;25(6):1846–1853.
  • Toyama T, Kitagawa K, Oshima M, et al. Age differences in the relationships between risk factors and loss of kidney function: a general population cohort study. BMC Nephrol. 2020;21(1):1–9.
  • Koraishy FM, Hooks-Anderson D, Salas J, et al. Fast GFR decline and progression to CKD among primary care patients with preserved GFR. Int Urol Nephrol. 2018;50(3):501–508.
  • Steubl D, Buzkova P, Garimella PS, et al. Association of serum uromodulin with ESKD and kidney function decline in the elderly: the cardiovascular health study. Am J Kidney Dis. 2019;74(4):501–509.
  • Nishimoto M, Murashima M, Yoshida H, et al. Impact of self-reported walking habit on slower decline in renal function among the general population in a longitudinal study: the Japan specific health checkups (J-SHC) study. J Nephrol. 2021;34(6):1845–1853.
  • Azizi F, Ghanbarian A, Momenan AA, et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran lipid and glucose study phase II. Trials. 2009;10(1):5.
  • Kriska AM, Knowler WC, LaPorte RE, et al. Development of questionnaire to examine relationship of physical activity and diabetes in pima indians. Diabetes Care. 1990;13(4):401–411.
  • Momenan AA, Delshad M, Sarbazi N, et al. Reliability and validity of the modifiable activity questionnaire (MAQ) in an Iranian urban adult population. Arch Iran Med. 2012;15(5):279–282.
  • Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560–2572.
  • Levey AS, Eckardt K-U, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int. 2005;67(6):2089–2100.
  • Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612.
  • Earley A, Miskulin D, Lamb EJ, et al. Estimating equations for glomerular filtration rate in the era of creatinine standardization: a systematic review. Ann Intern Med. 2012;156(11):785–795.
  • Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94(446):496–509.
  • Rajaeefard A, Mohammad-Beigi A, Mohammad-Salehi N. Estimation of natural age of menopause in iranian women: a meta-analysis study. Koomesh. 2011;13(1):1–7.
  • Bodner TE. What improves with increased missing data imputations? Struct Equ Modeling. 2008;15(4):651–675.
  • White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30(4):377–399.
  • Welch C, Bartlett J, Petersen I. Application of multiple imputation using the two-fold fully conditional specification algorithm in longitudinal clinical data. Stata J. 2014;14(2):418–431.
  • Rubin DB. Multiple imputation for nonresponse in surveys. New York: John Wiley & Sons; 2004.
  • Baba M, Shimbo T, Horio M, et al. Longitudinal study of the decline in renal function in healthy subjects. PLOS One. 2015;10(6):e0129036.
  • O’Hare AM, Choi AI, Bertenthal D, et al. Age affects outcomes in chronic kidney disease. J Am Soc Nephrol. 2007;18(10):2758–2765.
  • Chang W-X, Arai S, Tamura Y, et al. Time-dependent risk factors associated with the decline of estimated GFR in CKD patients. Clin Exp Nephrol. 2016;20(1):58–70.
  • Van Pottelbergh G, Bartholomeeusen S, Buntinx F, et al. The evolution of renal function and the incidence of end-stage renal disease in patients aged≥ 50 years. Nephrol Dial Transplant. 2012;27(6):2297–2303.
  • Kaewput W, Thongprayoon C, Chewcharat A, et al. Rate of kidney function decline and factors predicting progression of kidney disease in type 2 diabetes mellitus patients with reduced kidney function: a nationwide retrospective cohort study. Ther Apher Dial. 2020;24(6):677–687.
  • Nelson RG, Grams ME, Ballew SH, et al. Development of risk prediction equations for incident chronic kidney disease. JAMA. 2019;322(21):2104–2114.
  • Bairey Merz CN, Dember LM, Ingelfinger JR, et al. Sex and the kidneys: current understanding and research opportunities. Nat Rev Nephrol. 2019;15(12):776–783.
  • Murphy D, McCulloch CE, Lin F, et al. Trends in prevalence of chronic kidney disease in the United States. Ann Intern Med. 2016;165(7):473–481.
  • Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease–a systematic review and meta-analysis. PLOS One. 2016;11(7):e0158765.
  • Mills KT, Xu Y, Zhang W, et al. A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010. Kidney Int. 2015;88(5):950–957.
  • Iseki K, Nakai S, Shinzato T, et al. Patient registration committee of the Japanese society for dialysis T. Increasing gender difference in the incidence of chronic dialysis therapy in Japan. Ther Apher Dial. 2005;9(5):407–411.
  • Hecking M, Bieber BA, Ethier J, et al. Sex-specific differences in hemodialysis prevalence and practices and the male-to-female mortality rate: the dialysis outcomes and practice patterns study (DOPPS). PLOS Med. 2014;11(10):e1001750.
  • Gilg J, Castledine C, Fogarty D. UK RRT incidence in 2010: national and Centre-Specific analyses. Nephron Clin Pract. 2012;120(s1):c1–c27.
  • Rezaei S, Mahmoudi Z, Sheidaei A, et al. Salt intake among iranian population: the first national report on salt intake in Iran. J Hypertens. 2018;36(12):2380–2389.
  • Klahr S, Levey AS, Beck GJ, et al. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med. 1994;330(13):877–884.
  • Chen TK, Sperati CJ, Thavarajah S, et al. Reducing kidney function decline in patients with CKD: core curriculum 2021. Am J Kidney Dis. 2021;77(6):969–983.
  • Bellizzi V, Di Iorio BR, De Nicola L, et al. Very low protein diet supplemented with ketoanalogs improves blood pressure control in chronic kidney disease. Kidney Int. 2007;71(3):245–251.
  • Cedillo-Couvert EA, Ricardo AC, Chen J, et al. Self-reported medication adherence and CKD progression. Kidney Int Rep. 2018;3(3):645–651.
  • Oori MJ, Mohammadi F, Norouzi-Tabrizi K, et al. Prevalence of medication adherence in patients with hypertension in Iran: a systematic review and meta-analysis of studies published in 2000–2018. Arya Atherosclerosis. 2019;15(2):82.
  • Abegaz TM, Shehab A, Gebreyohannes EA, et al. Nonadherence to antihypertensive drugs: a systematic review and meta-analysis. Medicine. 2017;96(4):e5641.
  • De Hauteclocque A, Ragot S, Slaoui Y, et al. The influence of sex on renal function decline in people with type 2 diabetes. Diabet Med. 2014;31(9):1121–1128.
  • Meguro S, Tomita M, Kabeya Y, et al. Factors associated with the decline of kidney function differ among eGFR strata in subjects with type 2 diabetes mellitus. Int J Endocrinol. 2012;2012:1–6.
  • Zhou W, Li Y, Ning Y, et al. Social isolation is associated with rapid kidney function decline and the development of chronic kidney diseases in middle-aged and elderly adults: findings from the China health and retirement longitudinal study (CHARLS). Front Med. 2021;8:782624.
  • Parvathaneni K, Surapaneni A, Ballew SH, et al. Association between midlife physical activity and incident kidney disease: the atherosclerosis risk in communities (ARIC) study. Am J Kidney Dis. 2021;77(1):74–81.
  • Collins AJ, Vassalotti JA, Wang C, et al. Who should be targeted for CKD screening? Impact of diabetes, hypertension, and cardiovascular disease. Am J Kidney Dis. 2009;53(3 Suppl 3):S71–S7.
  • Zhang L, Zhang P, Wang F, et al. Prevalence and factors associated with CKD: a population study from Beijing. Am J Kidney Dis. 2008;51(3):373–384.
  • Melsom T, Nair V, Schei J, et al. Correlation between baseline GFR and subsequent change in GFR in Norwegian adults without diabetes and in Pima Indians. Am J Kidney Dis. 2019;73(6):777–785.
  • Smyth A, O’Donnell MJ, Yusuf S, et al. Sodium intake and renal outcomes: a systematic review. Am J Hypertens. 2014;27(10):1277–1284.
  • Hadaegh F, Hasheminia M, Abdi H, et al. Prehypertension tsunami: a decade follow-up of an Iranian adult population. PLOS One. 2015;10(10):e0139412.
  • Tonelli M, Klarenbach SW, Lloyd AM, et al. Higher estimated glomerular filtration rates may be associated with increased risk of adverse outcomes, especially with concomitant proteinuria. Kidney Int. 2011;80(12):1306–1314.
  • Ali I, Chinnadurai R, Ibrahim ST, et al. Adverse outcomes associated with rapid linear and non-linear patterns of chronic kidney disease progression. BMC Nephrol. 2021;22(1):1–10.
  • Levey AS, De Jong PE, Coresh J, et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO controversies conference report. Kidney Int. 2011;80(1):17–28.
  • Kang SC, Jhee JH, Joo YS, et al. Association of reproductive lifespan duration and chronic kidney disease in postmenopausal women. Mayo Clin Proc. 2020;95(12):2621–2632.
  • Qian D, Wang Z-F, Cheng Y-C, et al. Early menopause may associate with a higher risk of CKD and all-cause mortality in postmenopausal women: an analysis of NHANES, 1999–2014. Front Med. 2022;9:823835.
  • Rogers JL, Mitchell AR, Maric C, et al. Effect of sex hormones on renal estrogen and angiotensin type 1 receptors in female and male rats. Am J Physiol Regul Integr Comp Physiol. 2007;292(2):R794–R799.
  • Potier M, Elliot SJ, Tack I, et al. Expression and regulation of estrogen receptors in mesangial cells: influence on matrix metalloproteinase-9. J Am Soc Nephrol. 2001;12(2):241–251.
  • Elliot SJ, Karl M, Berho M, et al. Estrogen deficiency accelerates progression of glomerulosclerosis in susceptible mice. Am J Pathol. 2003;162(5):1441–1448.
  • Goldberg I, Krause I. The role of gender in chronic kidney disease. EMJ. 2016;1(2):58–64.
  • Levey AS, Coresh J, Tighiouart H, et al. Measured and estimated glomerular filtration rate: current status and future directions. Nat Rev Nephrol. 2020;16(1):51–64.
  • Kwong Y-TD, Stevens LA, Selvin E, et al. Imprecision of urinary iothalamate clearance as a gold-standard measure of GFR decreases the diagnostic accuracy of kidney function estimating equations. Am J Kidney Dis. 2010;56(1):39–49.